women on retatrutide Timeline: When to Expect Results I’m not a prescriber —
Description
They should be considered superior in most patients, including those with HF and CKD.3 However, ischaemia prevention is superior for GLP-1 RAs, thus making them preferable in patients with predominant ASCVD risk.3 Differences in routes of administration and adverse effect profiles may also play a role in prescription decisions
Nooms disclaimer clearly states compounded semaglutide is not FDA approved and has not been reviewed for safety, efficacy, or quality
After reading the first section you should already understand why, but lets recap it here
March 3, 2025: Wegovy Removed From FDAs Drug Shortage List Wegovy has been removed from the U.S
and Stanford Yee M.D
Weight management is particularly important for obese patients with diabetes
